New drug shows promise for Hard-to-Treat HER2 cancers
NCT ID NCT06695845
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 24 times
Summary
This study tests a drug called zanidatamab in people with advanced solid tumors that have high levels of HER2 protein. Participants must have already tried at least one other cancer treatment. The goal is to see if the drug can shrink tumors or stop them from growing. This is not a cure; it aims to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Oncologists
RECRUITINGChicago Ridge, Illinois, 60415, United States
-
Alliance Cancer Specialists
RECRUITINGHorsham, Pennsylvania, 19044, United States
-
Arizona Oncology Associates, PC - NAHOA
RECRUITINGPrescott, Arizona, 86301, United States
-
Asan Medical Center
RECRUITINGSeoul, 05505, South Korea
-
Barbara Ann Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
-
Blue Ridge Cancer Care
RECRUITINGRoanoke, Virginia, 24014, United States
-
Florida Cancer Specialists - East
RECRUITINGWest Palm Beach, Florida, 33401, United States
-
Florida Cancer Specialists - Lake Nona
RECRUITINGOrlando, Florida, 32827, United States
-
Florida Cancer Specialists - North
RECRUITINGSt. Petersburg, Florida, 33705, United States
-
Florida Cancer Specialists - South
RECRUITINGFort Myers, Florida, 33901, United States
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Rocky Mountain Cancer Center
RECRUITINGLittleton, Colorado, 80120, United States
-
SCRI Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
-
Samsung Medical Center
RECRUITINGGangnam-gu, Seoul, 06351, South Korea
-
Seoul National University Bundang Hospital
RECRUITINGSeoul, 13620, South Korea
-
Seoul National University Hospital
RECRUITINGJongno-gu, Seoul, 03080, South Korea
-
Severance Hospital
RECRUITINGSeodaemun-gu, Seoul, 03722, South Korea
-
Tennessee Cancer Specialists
RECRUITINGKnoxville, Tennessee, 37909, United States
-
Texas Oncology - DFW
RECRUITINGDallas, Texas, 75246, United States
-
Texas Oncology - San Antonio
RECRUITINGSan Antonio, Texas, 78217, United States
-
Texas Oncology - West Texas
RECRUITINGAmarillo, Texas, 79124, United States
Conditions
Explore the condition pages connected to this study.